Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases

Yuehong Chen(Sichuan University), Liu C(Yale University)
Arthritis Research & Therapy
January 19, 2022
Cited by 13


Related Papers